A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial 11 de novembro de 2021 DOWNLOAD DO ARTIGO - DR. CONRADO R. HOFFMANN FILHO